NeuroSense Therapeutics Ltd. Interest Income, Deposits with Financial Institutions
NeuroSense Therapeutics Ltd. (NRSN) reported Interest Income, Deposits with Financial Institutions of $13.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeDepositsWithFinancialInstitutions · last filed 2026-03-31
| Period end | Interest Income, Deposits with Financial Institutions 12 month |
|---|---|
| 2025-12-31 | $13.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $2.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $178.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $91.00K 20-F · filed 2025-04-07 |